Navigation Links
USP announces new tool to help prevent medication mix-ups due to look alike/sound alike drug names

Rockville, Md., August 25, 2008 The U.S. Pharmacopeial (USP) Convention today announces a new drug safety tool designed to help patients, caregivers, pharmacists, physicians and others in avoiding medication errors that may occur because of drug names that look alike and/or sound alike. This "Drug Error Finder" is a searchable database of almost 1,500 commonly used drugs reported to be involved in medication mix-ups in the U.S. health care system since 2003. The database is publicly available at no cost on USP's Web site at

The Drug Error Finder is derived from a list of 1,470 unique drugs that were implicated in medication errors due to brand and/or generic drug names that look or sound alike and reported to USP's MEDMARXan anonymous database used by hospitals and health care systems across the United States to report, track and analyze medication errorsor to USP's Medication Errors Reporting Program. The list was included in USP's 8th annual MEDMARX Data Report, released in January 2008, which examined more than 26,000 error records related to similar drug names submitted to the database from 2003 to 2006. This is the largest known list of look alike, sound alike drug names in the world based on actual medication error reports.

"As more medications are approved for market each year and become available to Americans, the opportunity for potentially dangerous or even deadly errors due to drug mix-ups from look alike or sound alike names becomes increasingly high," said Diane Cousins, R.Ph., USP vice president of healthcare quality and information. "While one drug name may be nearly identical to that of another drug, the two could be used for completely different conditions. This presents a major public health threat, and we think this new tool can play an important role in helping to reduce patient risk associated with this problem."

One example of a drug involved in such errors reported to MEDMARX is Clonidine, a high blood pressure medication. In actual instances reported to USP, this drug was confused with multiple drugs, including Colchicine (used for gout), Cetirizine (an antihistamine), and Clonazepam and its brand name, Klonopin (used for anxiety and seizures). "As one can imagine, for someone with hypertension, receiving the wrong medication could present a potentially severe consequence," noted Cousins. "This is exactly the type of mix-up we think could be avoided through tools such as our Drug Error Finder. This may be useful to parties across the health care system who are involved in dispensing and administering medicationsand especially to caregivers and to patients, who should always remain vigilant and participate actively in their care." The 2008 MEDMARX Report found 25 different levels of individuals involved in similar name errors, from pharmacy technicians, nurses and physicians to patients and family members.

To use the Drug Error Finder, simply type in the name of the particular drug of interest. In addition to rapidly generating a list of medications that have been confused with that drug, the tool will also allow users to see the severity attributed to the reported errors involving the drug (ranging from Category A for "potential for error" to Category I for "death").

The Drug Error Finder is one component of USP's response to the Institute of Medicine's 2006 report, Preventing Medication Errors, which calls on the government and public health organizations to address medication errors resulting from similar labeling and packaging as well as confusingly similar drug names.


Contact: Sandra Kim
US Pharmacopeia

Related medicine news :

1. Hartwell Medical Announces Release of CombiCarrierII Scoop Backboard to EMS Market
2. iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products
3. NxStage Announces Presentation of Data at the American Society of Nephrologys Renal Week 2008 Annual Meeting
4. Allscripts Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
5. Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation
6. WellPoint Announces Appointments of Lori Beer as Executive Vice President and Chief Information Officer; Martin Miller as Senior Vice President, Chief Accounting Officer and Controller
7. Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program
8. American Elements Announces Expanded Bromide and Iodide Manufacturing Capacity
9. Cylex Announces Significant Expansions and Reassignments of Personnel
10. Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
11. The Brain Aneurysm Foundation Announces 2008 Research Grant Recipients
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... limb amputations in the United States. Podiatrists are well aware that psychology-based patient ... therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates mobile ... wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they are ... of North America (RSNA) 2015 annual meeting through December 3 in Chicago, Illinois, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and medical ... the devices for sale in the United States. Clarity is a Superior Dual ... Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... Atlanta, GA (PRWEB) , ... December 01, 2015 ... ... manufacturing, supports SACC-GA and SACC-USA through membership and leadership since 2008. ... and Chair for SACC-USA . Gary has spent a significant amount of ...
(Date:12/1/2015)... Charlotte, NC (PRWEB) , ... December 01, 2015 ... ... NHS Foundation Trust on receiving the 2015 HSJ Acute Sector Innovation Award on ... of improving the patient care experience, and propose exciting enhancements to the medical ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 ... through its wholly-owned UK subsidiary Proximagen Ltd., today announced ... novel, oral small molecule inhibitor of Vascular Adhesion Protein ... in the treatment of inflammatory disease. The VAP-1 inhibitor ... --> --> Under the terms ...
(Date:11/30/2015)... , 1 décembre 2015 ... exposition et conférence d,Asie portant sur ... sur l,industrie manufacturière, se tiendra à ... 20 au 22 avril 2016. ... Photo - ...
(Date:11/30/2015)... PUNE, India , December 1, 2015 ... --> adds "Endometriosis - ... that provides an overview on therapeutic pipeline ... capabilities to create effective counter strategies to ... by identifying new targets and MOAs to ...
Breaking Medicine Technology: